Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Vesterbacka

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2023
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 yearsHabiba Kamal, Karin Lindahl, Michael Ingre, et al.
Journal of Virology|July 7, 2021
Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a <i>Prevotella</i> AgonistMaike Sperk, Anoop T Ambikan, Shilpa Ray, et al.
AIDS (London, England)|September 11, 2015
Gut microbiota diversity predicts immune status in HIV-1 infectionPiotr Nowak, Marius Troseid, Ekatarina Avershina, et al.
Iscience|January 10, 2022
Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signalingSara Svensson Akusjärvi, Anoop T Ambikan, Shuba Krishnan, et al.
Scientific Reports|August 1, 2024
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIVAswathy Narayanan, Oscar Kieri, Jan Vesterbacka, et al.
NPJ Biofilms and Microbiomes|December 20, 2023
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIVShilpa Ray, Aswathy Narayanan, Jan Vesterbacka, et al.
Communications Biology|April 14, 2022
Peripheral blood CD4<sup>+</sup>CCR6<sup>+</sup> compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individualsSara Svensson Akusjärvi, Shuba Krishnan, Bianca B Jütte, et al.
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Molecular & Cellular Proteomics : MCP|October 7, 2021
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 ReplicationShuba Krishnan, Hampus Nordqvist, Anoop T Ambikan, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2023
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 yearsHabiba Kamal, Karin Lindahl, Michael Ingre, et al.
Journal of Virology|July 7, 2021
Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a <i>Prevotella</i> AgonistMaike Sperk, Anoop T Ambikan, Shilpa Ray, et al.
AIDS (London, England)|September 11, 2015
Gut microbiota diversity predicts immune status in HIV-1 infectionPiotr Nowak, Marius Troseid, Ekatarina Avershina, et al.
Iscience|January 10, 2022
Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signalingSara Svensson Akusjärvi, Anoop T Ambikan, Shuba Krishnan, et al.
Scientific Reports|August 1, 2024
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIVAswathy Narayanan, Oscar Kieri, Jan Vesterbacka, et al.
NPJ Biofilms and Microbiomes|December 20, 2023
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIVShilpa Ray, Aswathy Narayanan, Jan Vesterbacka, et al.
Communications Biology|April 14, 2022
Peripheral blood CD4<sup>+</sup>CCR6<sup>+</sup> compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individualsSara Svensson Akusjärvi, Shuba Krishnan, Bianca B Jütte, et al.
Molecular Medicine (Cambridge, Mass.)|May 13, 2022
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccineCaroline Boulouis, Tobias Kammann, Angelica Cuapio, et al.
Molecular & Cellular Proteomics : MCP|October 7, 2021
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 ReplicationShuba Krishnan, Hampus Nordqvist, Anoop T Ambikan, et al.
Ebiomedicine|July 15, 2023
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXIDPuran Chen, Peter Bergman, Ola Blennow, et al.
Pageof 4